Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Chemotherapy in Cervical Cancer with Para-Aortic Lymph Nodes
NCT03534713Phase 3Recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jul 2020
- Primary completion
- Sep 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, paclitaxel in Cervical Cancer (CC), sponsored by Centre hospitalier universitaire de Toulouse. Started Jul 2020; status: recruiting.
02
Drugs
carboplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT03534713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03534713.